← FDA Drug Approvals (Drugs@FDA)

CLOTRIMAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2023-10-16

Drug application

FDA Application #

ANDA216569

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLOTRIMAZOLE

Generic name

CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%

Active ingredients

CLOTRIMAZOLE

Dosage form

SOLUTION

Route

TOPICAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

Manufacturer

Allegis Holdings, LLC

First approval

2023-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown